Tradestie Institutional Equity Comparison Engine
MXCT vs TCMD โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
TCMD Overall Edge
TCMD Captures Institutional Edge (4โ0 Pillars ยท 7โ3 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Tactile Systems Technology, Inc. (TCMD) driven by superior Valuation, Growth & Margin, Momentum & Technical, Options & Structure. Fundamentally, MXCT trades at N/M Forward P/E with -85.5% operating margin (+48.7% YoY revenue) versus TCMD at 17.4x Forward P/E and 9.4% operating margin (+7.1% YoY). In options structure, MXCT sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against TCMD sits in CONSOLIDATION (15th %ile IV; Dealer Gamma Walls on Pro).
Valuation Winner
TCMD
MXCT N/M vs TCMD 17.4x Fwd P/E
Growth & Margin Winner
TCMD
Op Margin -85.5% vs 9.4% ยท YoY +48.7% vs +7.1%
Momentum & Technical Winner
TCMD
1Y -19.4% vs +5.7% ยท 52W Pos 63% vs 29%
Options & Structure Winner
TCMD
UNCLASSIFIED (N/A IV) vs CONSOLIDATION (15th %ile IV)
MXCT
NASDAQ
MaxCyte, Inc. Common Stock
Services-Commercial Physical & Biological Research
$1.37
+7.03% 1D
Market Cap
$132.2M
1M Return
-4.2%
1Y Return
-19.41%
Forward P/E
N/M
Unified AI Score
41.7 / 100
SELL
Tech 46.0
Fund 52.0
Flow 62.0
Mom 50.0
TCMD
NASDAQ
Tactile Systems Technology, Inc.
Surgical & Medical Instruments & Apparatus
$25.60
-1.5% 1D
Market Cap
$582.2M
1M Return
+8.75%
1Y Return
+5.65%
Forward P/E
17.4x
Unified AI Score
40.1 / 100
SELL
Tech 37.0
Fund 44.0
Flow 65.0
Mom 31.1
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
1Y Indexed Return:
MXCT -19.41%
TCMD +5.65%
Spread: +25.06 pp (TCMD Lead)
Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)
| Period | MXCT Revenue | TCMD Revenue | MXCT Op. Margin | TCMD Op. Margin | Margin Edge |
|---|---|---|---|---|---|
| FY2018 | N/A | $140M | N/A | 2.1% | TCMD |
| FY2019 | $10M | $190M | -93.7% | 5.5% | TCMD |
| FY2020 | $20M | $190M | -71.6% | -1.9% | TCMD |
| FY2021 | $20M | $210M | -84.3% | -0.8% | TCMD |
| FY2022 | $30M | $250M | -95.2% | -5.2% | TCMD |
| FY2023 | $20M | $270M | -247.7% | 6.6% | TCMD |
| FY2024 | $20M | $290M | -230.5% | 7.6% | TCMD |
| FY2025 | $20M | $330M | -247.6% | 8.9% | TCMD |
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | MXCT | TCMD | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $132.2M | $582.2M | Larger Scale | TCMD |
| Trailing P/E Ratio Valuation | N/M | 25.2x | Lower Multiple | TCMD |
| Forward P/E Ratio Valuation | N/M | 17.4x | Lower Multiple | TCMD |
| Revenue Growth (YoY) Growth | +48.7% | +7.1% | Higher Growth | MXCT |
| Operating Margin (TTM) Profitability | -85.5% | 9.4% | Higher Margin | TCMD |
| Net Profit Margin Profitability | -81.4% | 6.7% | Higher Margin | TCMD |
| Return on Equity (ROE) Capital Efficiency | -16.9% | 11.0% | Higher ROE | TCMD |
| 52-Week Range Position Momentum | 63% ($1โ$2) | 29% ($21โ$38) | Stronger Trend | MXCT |
| Beta / 30D Volatility Risk Regime | 1.19ฮฒ ยท 96% Vol | 0.95ฮฒ ยท 52% Vol | Lower Realized Risk | TCMD |
| Unified Institutional Score Composite Signal | 41.7 / 100 (SELL) | 40.1 / 100 (SELL) | Higher Composite | MXCT |
Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor
Full MXCT vs TCMD Buy Guide
MXCT
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
N/A
IV Regime
Unclassified
TCMD
CONSOLIDATION
98d in phase ยท OBV DISTRIBUTION
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
15th %ile
IV Regime
Compressed (<25th %ile)
Pillar 6 90-Day Technical & R&D Innovation Disclosures
Corporate R&D & Foundry Tracker
Neither MXCT nor TCMD registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.